Thiomed (Thiocolchicoside)

Quick links

Choose a section

Quick links to important sections

Advertisements

Thiomed (Thiocolchicoside)

Advertisements
Advertisements

Method of action: Muscle Relaxant

Treatment option:

Advertisements

Overview of Thiomed (Thiocolchicoside)

Property Description
Active ingredient Thiocolchicoside (INN)
Forms Oral (tablets, capsules), Parenteral (injection)
Pharmacological class Centrally Acting Muscle Relaxant
Common general purpose Relief of painful muscle contractures
Origin Semi-synthetic derivative of a natural glucoside

What Type of Medicine is Thiomed (Thiocolchicoside)?

Thiomed is a medicinal product containing the active ingredient Thiocolchicoside (INN), and it is formally classified as a Centrally Acting Muscle Relaxant. The primary function of this drug is to modulate muscular hyperactivity and tension via the central nervous system, thereby helping to relieve involuntary stiffness and spasm. It falls under the general pharmacological class of agents used for musculo-skeletal conditions, specifically categorized as ATC group M03BX05. This classification reflects its targeted action within the central nervous system, which is distinct from agents that work directly on peripheral muscle fibers. Thiocolchicoside is typically a prescription-only (Rx) medication.

Thiocolchicoside: Origin, Forms, and Composition

Thiocolchicoside is a semi-synthetic derivative that is chemically synthesized from colchicoside, a natural glucoside that can be isolated from plants like Gloriosa superba. The medicine is available in several dosage forms for systemic use, which typically include oral preparations, such as tablets, and parenteral forms, which are injectable solutions intended for intramuscular (IM) administration. Thiomed is predominantly manufactured as a single-active-ingredient product, focusing solely on the action of Thiocolchicoside. Other common brands with the same active ingredient include Muscoril and Myoril.

General Purpose: What Does Thiomed Help to Relieve?

The general purpose of Thiomed is to facilitate the reduction of painful muscle contractures and resulting stiffness. It acts as an adjunctive treatment, meaning it is intended to supplement and support other physical therapies and pain relief measures. For example, Thiocolchicoside is used for the treatment of acute painful muscle contractures. This means the drug provides support in relieving the acute physical discomfort caused by muscle spasm, such as that experienced in episodes of acute low back pain. Its use is applicable for musculoskeletal pathology accompanied by muscle spasm, playing a role in easing spasm-related symptoms and improving the limited range of motion.

Advertisements

What side effects are possible with Thiomed (Thiocolchicoside)?

Official Adverse Reactions and Safety Profile

The safety profile of Thiocolchicoside is documented by regulatory authorities, classifying reported effects by frequency and the body system affected. All documented side effects are based on data submitted to and reviewed by governmental health agencies.

Classification Examples of Officially Listed Adverse Reactions
Common (Nervous/Gastrointestinal) Drowsiness, Diarrhoea, Gastralgia (stomach pain).
Uncommon (Gastrointestinal/Skin) Nausea, Vomiting, Pruritus (itching), Erythema.
Rare (Immune) Urticaria (hives).
Frequency Not Known Anaphylactic shock, Angioedema, Seizures, Cytolytic or Cholestatic Hepatitis.

Serious adverse reactions documented in regulatory sources include Anaphylactic shock (a severe allergic reaction), Seizure or relapse of epileptic attacks, and cases of Hepatitis (liver inflammation), especially when the medicine is used with other hepatotoxic drugs. Fainting of vasomotor origin has also been reported, typically occurring shortly after intramuscular injection.

Safety Constraints and Special Populations

Official regulatory documents stipulate specific safety constraints regarding population groups and duration of use:

  • Genotoxicity Concern: A metabolite of Thiocolchicoside has been identified as a potential inducer of aneuploidy (abnormal chromosome number) in dividing cells. Because aneuploidy is recognized as a risk factor for teratogenicity, impaired male fertility, and spontaneous abortion, use at doses exceeding recommended limits or long-term use must be avoided.
  • Contraindications: The medicine is strictly contraindicated during pregnancy (entire period), lactation (breastfeeding), and in women of childbearing potential who are not using reliable contraception.
  • Pediatric Use: It is not recommended for use in children or adolescents under 16 years of age due to safety concerns.

These constraints define the official boundaries for the product's use, focusing on short-term application and prohibiting use in vulnerable populations.

Advertisements

Overdose and Emergency Response

Overdose Manifestations and Required Actions

Information concerning Thiomed (Thiocolchicoside) overdose is based strictly on regulatory prescribing information and details the clinical signs observed. The officially documented clinical manifestations following the intake of an excessive dose are limited primarily to digestive signs. These include the common gastrointestinal disturbances of vomiting and diarrhoea.

The official documentation does not explicitly list specific severe acute outcomes, such as major cardiovascular or neurological complications, as direct manifestations of overdose in the prescribing information’s dedicated section.

Overdose Entity Regulatory Statement
Documented Symptoms Vomiting, Diarrhoea
Specific Antidote No specific antidote is known
Treatment Protocol Symptomatic and supportive treatment

When to Seek Immediate Medical Help

The immediate action mandated by regulatory authorities following an accidental or suspected overdose is to seek medical supervision and contact a physician. Since no specific pharmacological antidote is known for Thiocolchicoside, the established procedure for management is entirely supportive.

This official requirement for medical contact ensures that the patient receives necessary monitoring by a physician. The overall management must focus on addressing the clinical manifestations and maintaining stability under observation. Patients must be monitored for any worsening of documented gastrointestinal signs or other emergent issues, as defined by the regulating body.

Advertisements

Therapeutic Uses of Thiomed (Thiocolchicoside)

What Thiomed (Thiocolchicoside) Treats: Main Uses and Benefits

Thiomed is commonly used to provide symptomatic support for conditions characterized by intense, painful muscle contractures and rigidity, such as lumbago (acute lower back pain), torticollis, or spasm associated with sciatica. The medication is used as an add-on treatment for these painful contractures resulting from spinal conditions. It is applied in situations where symptoms manifest as localized stiffness and excessive muscular tension, offering support that helps ease the overall symptom burden of sharp, distressing pain.

By targeting and generally helping to reduce muscular resistance, Thiomed contributes to improved comfort and may be part of symptomatic management used during physical rehabilitation or following post-traumatic injuries. It is typically applied when symptoms are pronounced and require short-term symptomatic assistance to manage the accompanying stiffness.

“This approach is relevant in contexts marked by increased discomfort or tension, supporting functional stability when acute manifestations interfere with routine activities.”


Quick Fact: Support for Symptoms Related to Painful Muscle Rigidity


Supporting Mobility in Musculoskeletal Conditions

This medication is relevant for conditions that result in restricted range of motion and compromised functional stability due to muscle tightness. It assists with maintaining functional stability when acute manifestations interfere with routine activities, supporting patients during episodes of heightened discomfort.

Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Thiomed (Thiocolchicoside) — Official Regulatory Information

Eligibility Scope

Populations for whom use is allowed (as stated in label):

  • Adults and adolescents from 16 years onwards.
  • Patients receiving it for adjuvant treatment of painful muscle contractures in acute spinal pathology.

Populations for whom use is contraindicated:

  • Patients with hypersensitivity to the active substance or any excipients.
  • Pregnant women (during the entire pregnancy period).
  • Breastfeeding women (during lactation).
  • Women of childbearing potential not using effective contraception.
  • Children and adolescents under 16 years of age.
Age-related eligibility rules: Age Group Regulatory Status / Rule
Children (under 16 years) Contraindicated due to safety concerns.
Adolescents and Adults Eligible from 16 years of age and older.

Condition-specific eligibility rules:

  • Use should be administered with caution to epileptic patients or patients with a risk of convulsions.
  • Not recommended for long-term treatment of chronic conditions.

Pregnancy and lactation eligibility status (if explicitly documented):

  • Pregnancy: Contraindicated.
  • Lactation (Breastfeeding): Contraindicated.

Connection to the overall eligibility profile

Official regulatory documents strictly define the eligible population for thiocolchicoside by prohibiting its use in several vulnerable groups, classifying pregnancy, lactation, and non-contracepting women as absolute contraindications. The label establishes a minimum eligible age of 16 years and explicitly restricts the medicine solely to short-term, acute use, while cautioning against use in patients with a risk of convulsions.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Thiocolchicoside, strictly based on regulatory prescribing information.


Pharmacodynamic Interactions

Co-administration with other medicines that have a muscle-relaxing effect on the musculoskeletal system may result in an additive increase of one another's impact, a documented pharmacodynamic effect. Likewise, use with other medicines that produce effects on the smooth muscles may lead to a possible increase in the incidence rate of side effects, requiring regulatory caution. The official product information does not specify any drug-drug interactions mediated by Cytochrome P450 enzymes or drug transporters.


Substance and Population-Specific Interactions

Entity Category Official Interaction Statement
Substance Interaction Concomitant use with alcohol is cautioned against due to the potential for additive sedation and drowsiness, which are recognized adverse effects.
Population-Specific Risk In patients with hepatic conditions, the co-administration of the drug with NSAIDs or Paracetamol has been associated with serious cases of fulminant hepatitis reported during post-market surveillance.

Interaction Structure Summary

The regulatory documentation defines the interaction structure primarily around pharmacodynamic reinforcement and specific co-administration risks in susceptible populations. There are no mandatory timing separation windows required for co-administered medicines, and the profile is notable for the absence of documented pharmacokinetic interaction patterns. Interaction classifications are generally limited to cautions regarding additive effects or specific organ-related risks.

Advertisements

Mechanism of Action

How Thiomed (Thiocolchicoside) Works

Thiocolchicoside primarily acts within the central nervous system (CNS), focusing on structures such as the spinal cord and brainstem. Its core mechanism involves modulating key inhibitory neurotransmitter systems, specifically interacting with both GABA-A and glycine receptors. Through these interactions, the drug dampens the excitability of motor neurons.

This influence on central inhibitory pathways interferes with the hyperactive reflex arc—the spasmogenic cascade—that drives sustained motor discharge. Modulation of these signal sequences affects the central regulation of muscle tone and influences motor reflex frequency, supporting a modified state within targeted motor pathways.

Beyond its primary CNS action, Thiocolchicoside demonstrates a secondary ability to influence specific molecular systems involved in the inflammatory response. This capacity to modulate the release and impact of certain pro-inflammatory mediators affects biochemical cascades related to nociception, influencing the drug's overall pharmacological profile without being a direct, potent anti-inflammatory agent.

Advertisements

Dosage and Administration Information

The use of systemic thiocolchicoside involves precise parameters regarding administration, dosage, and duration. This medication is available for systemic administration through two primary routes: the oral route (capsules or tablets) and the intramuscular (IM) injection route. Both routes follow a clear, standardized dosing protocol.


Approved Administration and Dosing

Feature Use Instructions
Routes of Administration Oral (tablets/capsules) and Intramuscular (IM) injection.
Standard Frequency Twice daily (every 12 hours) for both routes.
Max Oral Dose The maximum dose is 8 mg per dose, totaling 16 mg per day.
Max IM Dose The maximum dose is 4 mg per dose, totaling 8 mg per day.

Treatment Duration and Population Rules

Standard protocols specify that treatment with thiocolchicoside must be strictly short-term. The duration for oral use is limited to seven consecutive days, and treatment with the IM injection route is limited to five consecutive days. The medicine is indicated for adults and adolescents 16 years of age and older; its use in younger pediatric populations is prohibited.

For oral administration, the dose is typically swallowed whole with a glass of water. A key procedural condition is the avoidance of long-term use and the adherence to the maximal daily and per-course dose limits to ensure proper use. If a scheduled dose is missed, individuals should resume their regular dosing schedule and must not take a double dose to compensate.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Thiomed (Thiocolchicoside)


Evidence for Use in Painful Muscle Contractures

The research exploring Thiomed (Thiocolchicoside) primarily focuses on conditions characterized by painful muscle contractures and stiffness, such as those associated with episodes of acute low back pain. These studies were generally structured as short-term Randomized Controlled Trials (RCTs). RCTs are the design used in research to explore how symptoms change over time by comparing one substance, like Thiomed, against a non-treatment (placebo) or an active comparator.

Studies explored how symptoms changed over time in the study arm receiving Thiomed, often alongside other treatments, in two key areas: outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level. Scientific reviews analyzing the results from many of these individual trials have noted that while some trials described patterns related to pain measurements, scientific syntheses note that the evidence contributes to the broader understanding of symptom patterns but is characterized by limitations and variability. The findings were mixed across the different studies aggregated in the scientific syntheses.


Types of Studies and Outcomes Examined

The main study types available include short-term RCTs and scientific analyses like Systematic Reviews and Meta-analyses, which summarize data from multiple trials. Researchers focused on measuring specific outcomes like Pain intensity and functional status. Functional status was evaluated using structured questionnaires that measure mobility and the ability to perform daily activities as measured by the questionnaires.

Findings describe patterns of observation in the studies related to short-term symptom patterns. However, scientific assessments frequently indicate that the certainty remains low, particularly because many of the individual trials used have been associated with methodological limitations or a potential risk of bias.


Study Duration and Available Follow-up Data

Studies typically involved follow-up durations that were limited, often only lasting for a few days up to two weeks. Because the current evidence is derived from studies observing responses over defined time intervals that are very short, there is limited information for long-term outcomes or sustained effects. Long-term effects are not fully established, and this lack of data means that research does not extend to chronic (long-term) conditions.

Key Studies & References Efficacy and Safety of the Combination of Diclofenac and Thiocolchicoside in the Treatment of Low Back Pain and Other Conditions: Systematic Review of the Literature (2025)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Thiomed (Thiocolchicoside) (FAQ)


Q: Does Thiomed cause drowsiness or make you sleepy?

A: Regulatory documents list drowsiness as a commonly reported adverse reaction. This effect is a recognized possibility that is noted in official information.

Q: Is it okay to drive while taking Thiomed?

A: Official information advises caution regarding operating vehicles or heavy machinery. Because drowsiness is a reported side effect, the possibility of impairment is noted in connection with activities that require alertness.

Q: Does Thiomed interact with alcohol?

A: Concomitant use with alcohol is cautioned against in official documents. This warning is based on the potential for additive effects, such as increased sedation or drowsiness, when the two substances are combined.

Q: How quickly does Thiomed start to work?

A: Pharmacokinetic data provides a timeline for the medicine entering the bloodstream. After an intramuscular injection, the highest levels of the medicine in the blood are reached in about 30 minutes. After oral administration, maximum concentrations of the active component are reached in approximately 1 hour.

Q: How long do the effects of Thiomed usually last?

A: Official data on how the body processes the medicine indicates that the time it takes for the unchanged substance to be reduced by half (half-life) is approximately 1.5 hours after injection. The active component's half-life ranges from 3.2 to 7 hours after oral use.

Q: Can I take Thiomed if I have a sensitive stomach?

A: Gastrointestinal issues are reported possibilities, with side effects including diarrhea, nausea, vomiting, and stomach pain (gastralgia). Official regulatory guidance notes that in cases where diarrhea is experienced, dose reduction or withdrawal of the product is sometimes part of the clinical management.

Q: Is it normal to feel dizzy after taking Thiomed?

A: Dizziness is listed in some regulatory documents as a possible adverse effect. Additionally, fainting of vasomotor origin has been reported, particularly following the intramuscular injection route.

Q: Can Thiomed affect your liver health?

A: Serious adverse reactions, including cytolytic or cholestatic hepatitis (liver inflammation), have been documented in official sources. Caution is advised when the medicine is used in combination with other drugs known to pose a risk to the liver.

Q: Does Thiomed interact with common pain relievers?

A: Regulatory documents mention a risk of fulminant hepatitis (severe liver inflammation) when Thiomed is co-administered with common non-steroidal anti-inflammatory drugs (NSAIDs) or Paracetamol in patients with pre-existing hepatic conditions. Outside of this specific liver risk, the interaction profile is noted for the absence of documented effects on how other drugs are processed by the body.

Q: Does Thiomed cause stomach upset or nausea?

A: Nausea and vomiting are listed as known uncommon adverse reactions, while diarrhea is a commonly reported gastrointestinal issue.

Q: What happens if I miss a dose of Thiomed?

A: Official instructions define the proper procedure as resuming the regular dosing schedule. Regulatory documents state that a double dose must not be taken to compensate for a missed dose.

Q: Can Thiomed be split or crushed?

A: Official instructions for oral administration state that tablets should typically be swallowed whole with water. Regulatory documents do not provide information or guidance on the practice of splitting or crushing the tablets.

Q: What is the 'safety profile' of Thiomed?

A: The safety profile is defined by strict regulatory constraints, including specific maximum dose and duration limits. It is strictly contraindicated during pregnancy, lactation, and for women of childbearing potential not using contraception. Caution is also mandatory for patients with a risk of convulsions.

Q: What research exists about the long-term use of Thiomed?

A: Official regulatory documents mandate that long-term use of Thiomed must be avoided. The evidence supporting the medicine is derived from short-term studies, and the effects beyond these defined, limited time intervals are not fully established.

Q: Is Thiomed a type of anti-inflammatory drug?

A: Thiomed is formally classified as a centrally acting muscle relaxant. Regulatory documents note a secondary capacity to influence molecular systems involved in the inflammatory response, but it is not classified as a potent, direct anti-inflammatory drug.

Q: Is Thiomed used for long-term pain management?

A: No. Official regulatory documents strictly restrict the treatment duration for this medicine to short-term use. Treatment limits are seven consecutive days for oral forms and five consecutive days for the intramuscular injection route, indicating it is not intended for chronic (long-term) pain management.

Q: Why do doctors prescribe Thiomed instead of just a regular painkiller?

A: Thiomed is prescribed as an adjunctive (supplementary) treatment for painful muscle contractures due to its primary action as a centrally acting muscle relaxant. This function involves targeting the central nervous system to help relieve involuntary stiffness and spasm, which is distinct from the function of typical painkillers.

Q: Does taking Thiomed require any special monitoring?

A: Regulatory guidance suggests that caution is warranted in patients who have epilepsy or a risk of convulsions. Additionally, regulatory warnings highlight the need for caution, particularly regarding liver risk when taken concurrently with certain pain relievers, implying clinical vigilance.

Q: Are there any foods or drinks to avoid while taking Thiomed?

A: The only substance specifically cautioned against in the official interaction profile is alcohol, due to the risk of increased sedation. Regulatory documents do not specify any other interactions with food.

Q: Does Thiomed come in different strengths?

A: Yes. Thiomed is officially available for systemic use in oral strengths of 4 mg and 8 mg tablets or capsules. It is also available as an injectable solution, typically containing 4 mg per ampoule, intended for intramuscular administration.

Q: Is there official research showing Thiomed helps with back pain?

A: Official documents indicate that the medicine is approved for the adjunctive treatment of painful muscle contractures in acute spinal pathology, which includes conditions such as acute low back pain. The evidence supporting its use is derived from short-term studies (Randomized Controlled Trials) that examined outcomes related to pain and functional status.

Q: Does Thiomed have a sedative effect?

A: Drowsiness (somnolence) is listed as a common adverse reaction, and its use with alcohol can cause additive sedation. While some pharmacological information suggests the medicine may not have an inherent sedative effect, the possibility of drowsiness is a recognized side effect.

Q: Is it true that Thiomed has been reviewed by major drug agencies?

A: Yes, official regulatory documents confirm that the medicine's safety profile and use restrictions have been subject to full assessment and review by major governmental health agencies, such as the European Medicines Agency (EMA).

Q: Why do people use Thiomed?

A: People use Thiomed for the adjunctive treatment of painful muscle contractures and associated stiffness. Its use is based on its primary function as a centrally acting muscle relaxant, which works to modulate muscle hyperactivity.

Q: What should I know about the safety warnings related to Thiomed?

A: Official warnings include strictly avoiding doses that exceed the recommended limits and avoiding long-term use. This is due to a potential risk of chromosome changes (aneuploidy) associated with a metabolite. The medicine is also subject to absolute contraindications for use in pregnant women, breastfeeding women, and women of childbearing potential not using effective contraception.

Advertisements

How should Thiomed (Thiocolchicoside) be stored and disposed of?

Official Storage and Disposal Requirements

Thiomed (Thiocolchicoside) must be stored strictly according to the conditions defined in the official regulatory labeling to maintain its stability and effectiveness. The product requires storage below 30 C and must be protected from both light and moisture. This controlled environment supports the product's labeled shelf life, which is typically three years for the oral dosage form.

Handling and Safety

It is a mandatory regulatory requirement to keep this medicine out of the sight and reach of children.

Disposal of Unused Medicine

Disposal must be executed in accordance with local regulatory requirements for pharmaceutical waste. The official instruction states that the product should not be disposed of via household wastewater or allowed to enter the environment, drains, or soil.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Thiomed (Thiocolchicoside) found in:

A-Z Index: